A detailed history of Cerity Partners LLC transactions in Omeros Corp stock. As of the latest transaction made, Cerity Partners LLC holds 26,389 shares of OMER stock, worth $233,278. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,389
Previous 26,431 0.16%
Holding current value
$233,278
Previous $107,000 2.8%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$3.54 - $5.47 $148 - $229
-42 Reduced 0.16%
26,389 $104,000
Q2 2024

Aug 13, 2024

BUY
$3.04 - $4.23 $13,917 - $19,364
4,578 Added 20.95%
26,431 $107,000
Q1 2024

May 14, 2024

BUY
$2.88 - $4.89 $8 - $14
3 Added 0.01%
21,853 $75,000
Q4 2023

Jan 26, 2024

BUY
$1.08 - $3.63 $23,598 - $79,315
21,850 New
21,850 $71,000
Q2 2023

Aug 14, 2023

BUY
$4.45 - $7.57 $31,150 - $52,990
7,000 Added 44.16%
22,850 $124,000
Q4 2022

Feb 15, 2023

SELL
$1.75 - $3.96 $28,875 - $65,340
-16,500 Reduced 51.0%
15,850 $35,000
Q3 2022

Nov 10, 2022

SELL
$3.09 - $7.46 $8,652 - $20,888
-2,800 Reduced 7.97%
32,350 $102,000
Q2 2022

Aug 10, 2022

BUY
$1.92 - $6.28 $1,344 - $4,396
700 Added 2.03%
35,150 $97,000
Q3 2021

Oct 25, 2021

BUY
$13.4 - $16.3 $32,160 - $39,120
2,400 Added 7.49%
34,450 $475,000
Q2 2021

Aug 11, 2021

BUY
$14.81 - $19.13 $20,734 - $26,782
1,400 Added 4.57%
32,050 $476,000
Q1 2021

Aug 11, 2021

SELL
$14.52 - $23.53 $131,551 - $213,181
-9,060 Reduced 22.82%
30,650 $546,000
Q1 2021

May 12, 2021

BUY
$14.52 - $23.53 $177,652 - $287,889
12,235 Added 44.53%
39,710 $707,000
Q4 2020

Feb 11, 2021

BUY
$10.14 - $15.19 $278,596 - $417,345
27,475 New
27,475 $392,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $555M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.